Welcome to the EHC ‘COVID-19 resource page,’ where we try to compile a series of resources on the current covid-19 epidemic with a particular focus on rare bleeding disorders.

Announcements from regulatory agencies

World Health Organisation


European Medicine Agency


European Centre for Disease Prevention and Control

Scientific publications and literature review

Clinical findings in a patient with haemophilia A affected by COVID-19, Letter to the editor accepted in the Haemophilia journal, Apr. 01

REACTing is a collaborative network of major French research institutions, coordinated by Inserm (French National Institute of Health and Medical Research), which aims to optimise research capacity during epidemics & improve research preparedness in between epidemics through multi-disciplinary collaboration. 
REACTing shares a selection of the most relevant articles published on COVID-19 on a bi-weekly basis. This literature review not only presents a selection of references, but also highlights the key points and messages from each article. It does not include pre-print articles.

Access the literature review here.

Resources from patients, clinicians and other public health organisations

European Haemophilia Consortium (EHC)

World Federation of Hemophilia (WFH)

EURORDIS – Rare Disease Europe


European Patients Forum

International Society for Thrombosis and Haemostasis (ISTH)

European Observatory on Health Systems and Policies
The Health System Response Monitor (HSRM) has been designed in response to the COVID-19 outbreak to collect and organise up-to-date information on how countries are responding to the crisis. It focuses primarily on the responses of health systems but also captures wider public health initiatives.
This is a joint undertaking of the WHO Regional Office for Europe, the European Commission, and the European Observatory on Health Systems and Policies.
Access the HSRM here.


John Hopkins coronavirus dashboard


EuroHealthNet is a not-for-profit partnership of organisations, agencies and statutory bodies working on public health, disease prevention, promoting health, and reducing inequalities.

Resources from the pharmaceutical industry

Plasma Protein Therapeutics Association (PPTA) – Novel coronavirus disease (COVID-19) resources